drugset / Trial / NCT05264714

Cluster Headache Treatment With Rimegepant

NCT05264714

Phase 2 Completed 20 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to explore the efficacy of rimegepant as a preventative therapy for cluster headache.

Timeline

Start
2022-09-07
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Rimegepant Small molecule 150 mg Oral